Back
Janus Henderson AAA CLO ETF Vs. Neurocrine Biosciences, Inc. Industry Stock Comparison
Sell
25
JAAA
Janus Henderson AAA CLO ETF
Last Price:
$50.60
Seasonality Move:
0.06%
Buy
62
NBIX
Neurocrine Biosciences, Inc.
Last Price:
$139.93
Seasonality Move:
3.52%
Sell
25
Janus Henderson AAA CLO ETF (JAAA)
is a Sell
Is Janus Henderson AAA CLO ETF a Buy, Sell or Hold?
-
The current Janus Henderson AAA CLO ETF [JAAA] share price is $50.58. The Score for JAAA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
JAAA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Is Neurocrine Biosciences, Inc. a Buy, Sell or Hold?
-
The current Neurocrine Biosciences, Inc. [NBIX] share price is $141.83. The Score for NBIX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
NBIX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JAAA Stock Price Chart
What is Janus Henderson AAA CLO ETF's stock price today?
-
The Janus Henderson AAA CLO ETF share price today is $50.58The current trend is relatively stagnant and JAAA is experiencing slight selling pressure.
NBIX Stock Price Chart
What is Neurocrine Biosciences, Inc.'s stock price today?
-
The Neurocrine Biosciences, Inc. share price today is $141.83Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing slight buying pressure.
JAAA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 50.58 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.51 - 50.65) | Sell |
| Bollinger Bands (100): | (50.57 - 50.73) | Sell |
NBIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.32 | Sell |
| Relative Strength Index (14 RSI): | 40.12 | Sell |
| Chaikin Money Flow: | 405745 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (144.24 - 154.18) | Sell |
| Bollinger Bands (100): | (136.24 - 149.22) | Sell |
JAAA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.56 | Buy |
| 20-day SMA: | 50.56 | Buy |
| 50-day SMA: | 50.61 | Sell |
| 200-day SMA: | 50.59 | Sell |
| 8-day EMA: | 50.56 | Buy |
| 20-day EMA: | 50.57 | Buy |
| 50-day EMA: | 50.6 | Sell |
| 200-day EMA: | 50.63 | Sell |
NBIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 144.8 | Sell |
| 20-day SMA: | 148.98 | Sell |
| 50-day SMA: | 146.78 | Sell |
| 200-day SMA: | 130.9 | Buy |
| 8-day EMA: | 144.31 | Sell |
| 20-day EMA: | 146.5 | Sell |
| 50-day EMA: | 145.88 | Sell |
| 200-day EMA: | 136.68 | Buy |
Janus Henderson AAA CLO ETF Earnings Growth & JAAA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurocrine Biosciences, Inc. Earnings Growth & NBIX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.26 per share, and an increase next year of $1.51 per share.
Janus Henderson AAA CLO ETF Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurocrine Biosciences, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||